Search research articles
Contact Us
Filters
Showing results (31-40 of 105) with videos related to
Page
of 11
Sort By:
International Archives of Allergy and Immunology
|
January 1, 1992
Alginate--its role in neutrophil responses and signal transduction towards mucoid Pseudomonas aeruginosa bacteria
B König, P Friedl, S S Pedersen, et al.
Journal of Clinical Microbiology
|
April 1, 1990
Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis
S S Pedersen, F Espersen, N Høiby, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
December 10, 2015
Patient-reported health status prior to cardiac resynchronisation therapy identifies patients at risk for poor survival and prolonged hospital stays
H Versteeg, J Denollet, M Meine, et al.
Acta Paediatrica Scandinavica
|
November 1, 1988
Excretion of urinary collagen metabolites correlates to severity of pulmonary disease in cystic fibrosis
T Ammitzbøll, S S Pedersen, F Espersen, et al.
Reviews of Infectious Diseases
|
May 1, 1991
Safety of aztreonam in patients with cystic fibrosis and allergy to beta-lactam antibiotics
T Jensen, S S Pedersen, N Høiby, et al.
Thorax
|
January 1, 1992
Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis
S S Pedersen, N Høiby, F Espersen, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1987
Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis
S S Pedersen, T Jensen, D Osterhammel, et al.
European Journal of Clinical Microbiology
|
December 1, 1987
Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis
T Jensen, S S Pedersen, N Høiby, et al.
Antibiotics and Chemotherapy
|
January 1, 1991
Alginate in infection
S S Pedersen, N Høiby, F Espersen, et al.
Lancet (London, England)
|
June 6, 1987
Aztreonam for cystic fibrosis patients who are hypersensitive to other beta-lactams
T Jensen, C Koch, S S Pedersen, et al.
Page
of 11
Search research articles
Search
Showing results (31-40 of 105) with videos related to
Sort By:
Page
of 11
International Archives of Allergy and Immunology
|
January 1, 1992
Alginate--its role in neutrophil responses and signal transduction towards mucoid Pseudomonas aeruginosa bacteria
B König, P Friedl, S S Pedersen, et al.
Journal of Clinical Microbiology
|
April 1, 1990
Immunoglobulin A and immunoglobulin G antibody responses to alginates from Pseudomonas aeruginosa in patients with cystic fibrosis
S S Pedersen, F Espersen, N Høiby, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
|
December 10, 2015
Patient-reported health status prior to cardiac resynchronisation therapy identifies patients at risk for poor survival and prolonged hospital stays
H Versteeg, J Denollet, M Meine, et al.
Acta Paediatrica Scandinavica
|
November 1, 1988
Excretion of urinary collagen metabolites correlates to severity of pulmonary disease in cystic fibrosis
T Ammitzbøll, S S Pedersen, F Espersen, et al.
Reviews of Infectious Diseases
|
May 1, 1991
Safety of aztreonam in patients with cystic fibrosis and allergy to beta-lactam antibiotics
T Jensen, S S Pedersen, N Høiby, et al.
Thorax
|
January 1, 1992
Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis
S S Pedersen, N Høiby, F Espersen, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 1987
Cumulative and acute toxicity of repeated high-dose tobramycin treatment in cystic fibrosis
S S Pedersen, T Jensen, D Osterhammel, et al.
European Journal of Clinical Microbiology
|
December 1, 1987
Efficacy of oral fluoroquinolones versus conventional intravenous antipseudomonal chemotherapy in treatment of cystic fibrosis
T Jensen, S S Pedersen, N Høiby, et al.
Antibiotics and Chemotherapy
|
January 1, 1991
Alginate in infection
S S Pedersen, N Høiby, F Espersen, et al.
Lancet (London, England)
|
June 6, 1987
Aztreonam for cystic fibrosis patients who are hypersensitive to other beta-lactams
T Jensen, C Koch, S S Pedersen, et al.
Page
of 11